These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 34612675

  • 1. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
    Li P, Wang X, Sun X, Guan Z, Sun W.
    mSphere; 2021 Oct 27; 6(5):e0069921. PubMed ID: 34612675
    [Abstract] [Full Text] [Related]

  • 2. Recombinant Pseudomonas Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection.
    Li P, Wang X, Sun X, Cimino J, Guan Z, Sun W.
    Infect Immun; 2021 Oct 15; 89(11):e0039621. PubMed ID: 34310892
    [Abstract] [Full Text] [Related]

  • 3. Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice.
    Zhang X, Yang F, Zou J, Wu W, Jing H, Gou Q, Li H, Gu J, Zou Q, Zhang J.
    Vaccine; 2018 Feb 14; 36(8):1047-1054. PubMed ID: 29406241
    [Abstract] [Full Text] [Related]

  • 4. A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa.
    Aguilera-Herce J, García-Quintanilla M, Romero-Flores R, McConnell MJ, Ramos-Morales F.
    mSphere; 2019 Apr 17; 4(2):. PubMed ID: 30996108
    [Abstract] [Full Text] [Related]

  • 5. The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia.
    Naito Y, Hamaoka S, Kinoshita M, Kainuma A, Shimizu M, Katoh H, Moriyama K, Ishii KJ, Sawa T.
    Microbiol Immunol; 2018 Dec 17; 62(12):774-785. PubMed ID: 30378708
    [Abstract] [Full Text] [Related]

  • 6. Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa.
    Das S, Howlader DR, Zheng Q, Ratnakaram SSK, Whittier SK, Lu T, Keith JD, Picking WD, Birket SE, Picking WL.
    Front Immunol; 2020 Dec 17; 11():583008. PubMed ID: 33281815
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K, Wiener-Kronish JP, Sawa T.
    Microbiol Immunol; 2009 Nov 17; 53(11):587-94. PubMed ID: 19903258
    [Abstract] [Full Text] [Related]

  • 8. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
    Fakoor MH, Owlia P, Mousavi Gargari SL, Sabokbar A.
    Iran J Immunol; 2020 Jun 17; 17(2):121-136. PubMed ID: 32602466
    [Abstract] [Full Text] [Related]

  • 9. Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
    Baker SM, Pociask D, Clements JD, McLachlan JB, Morici LA.
    Vaccine; 2019 Feb 04; 37(6):808-816. PubMed ID: 30638799
    [Abstract] [Full Text] [Related]

  • 10. Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models.
    Ranjbar M, Behrouz B, Norouzi F, Mousavi Gargari SL.
    Mol Immunol; 2019 Dec 04; 116():98-105. PubMed ID: 31634816
    [Abstract] [Full Text] [Related]

  • 11. Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia.
    Hamaoka S, Naito Y, Katoh H, Shimizu M, Kinoshita M, Akiyama K, Kainuma A, Moriyama K, Ishii KJ, Sawa T.
    Microbiol Immunol; 2017 Feb 04; 61(2):64-74. PubMed ID: 28370521
    [Abstract] [Full Text] [Related]

  • 12. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T, Ito E, Nguyen VH, Haight M.
    Hum Vaccin Immunother; 2014 Feb 04; 10(10):2843-52. PubMed ID: 25483637
    [Abstract] [Full Text] [Related]

  • 13. Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections.
    Asadi Karam MR, Badmasti F, Ahmadi K, Habibi M.
    Sci Rep; 2022 Jan 25; 12(1):1325. PubMed ID: 35079054
    [Abstract] [Full Text] [Related]

  • 14. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
    Elhosary MA, Bahey-El-Din M, AbdelBary A, El Guink N, Aboushleib HM.
    Microb Pathog; 2019 Jun 25; 131():181-185. PubMed ID: 30978430
    [Abstract] [Full Text] [Related]

  • 15. PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.
    Holder IA, Neely AN, Frank DW.
    Infect Immun; 2001 Sep 25; 69(9):5908-10. PubMed ID: 11500471
    [Abstract] [Full Text] [Related]

  • 16. A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.
    Warrener P, Varkey R, Bonnell JC, DiGiandomenico A, Camara M, Cook K, Peng L, Zha J, Chowdury P, Sellman B, Stover CK.
    Antimicrob Agents Chemother; 2014 Aug 25; 58(8):4384-91. PubMed ID: 24841258
    [Abstract] [Full Text] [Related]

  • 17. Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa.
    Saha S, Takeshita F, Sasaki S, Matsuda T, Tanaka T, Tozuka M, Takase K, Matsumoto T, Okuda K, Ishii N, Yamaguchi K, Klinman DM, Xin KQ, Okuda K.
    Vaccine; 2006 Sep 11; 24(37-39):6240-9. PubMed ID: 16806598
    [Abstract] [Full Text] [Related]

  • 18. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
    Golpasha ID, Mousavi SF, Owlia P, Siadat SD, Irani S.
    Bosn J Basic Med Sci; 2015 May 25; 15(2):15-24. PubMed ID: 26042508
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Daniel C, Titecat M, Poiret S, Cayet D, Boutillier D, Simonet M, Sirard JC, Lemaître N, Sebbane F.
    Vaccine; 2016 Nov 11; 34(47):5762-5767. PubMed ID: 27742220
    [Abstract] [Full Text] [Related]

  • 20. Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa.
    Wan C, Zhang J, Zhao L, Cheng X, Gao C, Wang Y, Xu W, Zou Q, Gu J.
    Front Immunol; 2019 Nov 11; 10():781. PubMed ID: 31068928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.